Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 20,287 calls trading, 1.0x expected, and implied vol increasing almost 53 points to 131.78%. 7/11 weekly 5.5 calls and 7/11 weekly 5 calls are the most active options, with total volume in those strikes near 6,000 contracts. The Put/Call Ratio is 0.13. Earnings are expected on August 7th.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX:
- Strategic Acquisition and Market Positioning Drive Buy Rating for Recursion Pharmaceuticals
- Rallybio Stock (RLYB) Rockets 25% on a Recursion Pharmaceuticals Agreement
- Recursion Pharmaceuticals Acquires ENPP1 Inhibitor Program
- Rallybio to sell interest in REV102 to Recursion Pharmaceuticals for up to $25M
- Recursion Pharmaceuticals acquires full rights to hypophosphatasia drug REV102